Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
Clinical trial NCT00937326 · COMPLETED
Trial details
- NCT number
- NCT00937326
- Sponsor
- Sirtris, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-19
- Primary completion
- 2010-09-18
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.